Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99.6M
-
Number of holders
-
202
-
Total 13F shares, excl. options
-
82.8M
-
Shares change
-
-496K
-
Total reported value, excl. options
-
$3.29B
-
Value change
-
-$26.8M
-
Put/Call ratio
-
0.33
-
Number of buys
-
108
-
Number of sells
-
-96
-
Price
-
$39.79
Significant Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q3 2015
237 filings reported holding NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock as of Q3 2015.
NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) has 202 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 82.8M shares
of 99.6M outstanding shares and own 83.11% of the company stock.
Largest 10 shareholders include FMR LLC (12.9M shares), PRICE T ROWE ASSOCIATES INC /MD/ (8.77M shares), VANGUARD GROUP INC (5.76M shares), ORBIMED ADVISORS LLC (3.82M shares), BlackRock Fund Advisors (3.34M shares), BB BIOTECH AG (3.17M shares), PERCEPTIVE ADVISORS LLC (2.94M shares), Visium Asset Management, LP (2.2M shares), Invesco Ltd. (2.18M shares), and STATE STREET CORP (2.02M shares).
This table shows the top 202 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.